CathWorks
Dr. Alex Froimovich joins CathWorks with over 18 years of experience in the medical device industry. Dr. Froimovich has been integral to the development, commercialization, and evidence development of multiple lifesaving and life-changing innovative technologies globally, including the first drug-eluting stent, the market-leading transcatheter heart valve, and the most advanced deep brain stimulator. Dr. Froimovich brings a long track record in medical affairs and scientific communications successes at some of the leading medical device manufacturers such as Johnson & Johnson, Edwards Lifesciences, and Boston Scientific.
He earned his M.D. from the Pontificia Universidad Católica de Chile and his M.B.A. from Rutgers Business School.
This person is not in any teams
This person is not in any offices
CathWorks
1 followers
CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize Coronary Artery Disease (CAD) therapy decisions and elevate coronary angiography from visual assessment to an objective FFR-based decision-making tool for physicians.